CoRe-BT: A Multimodal Radiology-Pathology-Text Benchmark for Robust Brain Tumor Typing
This addresses the challenge of robust multimodal learning for brain tumor typing in realistic scenarios with incomplete clinical data, representing an incremental advancement.
The authors tackled the problem of accurate brain tumor typing by integrating heterogeneous clinical evidence, introducing CoRe-BT, a multimodal benchmark dataset with 310 patients, and demonstrated the feasibility of multimodal fusion with complementary modality contributions.
Accurate brain tumor typing requires integrating heterogeneous clinical evidence, including magnetic resonance imaging (MRI), histopathology, and pathology reports, which are often incomplete at the time of diagnosis. We introduce CoRe-BT, a cross-modal radiology-pathology-text benchmark for brain tumor typing, designed to study robust multimodal learning under missing modality conditions. The dataset comprises 310 patients with multi-sequence brain MRI (T1, T1c, T2, FLAIR), including 95 cases with paired H&E-stained whole-slide pathology images and pathology reports. All cases are annotated with tumor type and grade, and MRI volumes include expert-annotated tumor masks, enabling both region-aware modeling and auxiliary learning tasks. Tumors are categorized into six clinically relevant classes capturing the heterogeneity of common and rare glioma subtypes. We evaluate tumor typing under variable modality availability by comparing MRI-only models with multimodal approaches that incorporate pathology information when present. Baseline experiments demonstrate the feasibility of multimodal fusion and highlight complementary modality contributions across clinically relevant typing tasks. CoRe-BT provides a grounded testbed for advancing multimodal glioma typing and representation learning in realistic scenarios with incomplete clinical data.